Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Events & Presentations

Events & PresentationsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Spectrum Pharmaceuticals Acquires Talon Therapeutics, Inc. Conference Call

Jul 17, 2013 at 1:30 PM ET

Registration is required to listen to this webcast. * Required fields


 
This helps Spectrum Pharmaceuticals, Inc. prevent automated submissions.




** An email will be sent to your email address confirming your identity. You will then be given options to sign up for webcast and other alerts.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
7.62
Change:
- 0.03
Day High:
7.90
Day Low:
7.61
Volume:
376,900
12:40 PM ET on Oct 31, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company